211 related articles for article (PubMed ID: 10771966)
1. Prostaglandin E1: first stage palliation in neonates with congenital cardiac defects.
Reddy SC; Saxena A
Indian J Pediatr; 1998; 65(2):211-6. PubMed ID: 10771966
[TBL] [Abstract][Full Text] [Related]
2. Prostaglandin E1 in infants with congenital heart disease: Indian experience.
Saxena A; Sharma M; Kothari SS; Juneja R; Reddy SC; Sharma R; Bhan A; Venugopal P
Indian Pediatr; 1998 Nov; 35(11):1063-9. PubMed ID: 10216540
[TBL] [Abstract][Full Text] [Related]
3. Prostaglandin E1 treatment in patent ductus arteriosus dependent congenital heart defects.
Tálosi G; Katona M; Rácz K; Kertész E; Onozó B; Túri S
J Perinat Med; 2004; 32(4):368-74. PubMed ID: 15346826
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of alprostadil (prostaglandin E1) in the management of congenital heart disease in infancy.
Heymann MA; Clyman RI
Pharmacotherapy; 1982; 2(3):148-55. PubMed ID: 6763200
[TBL] [Abstract][Full Text] [Related]
5. Nursing care of the neonate receiving prostaglandin E1 therapy.
Rikard DH
Neonatal Netw; 1993 Jun; 12(4):17-22. PubMed ID: 8510622
[TBL] [Abstract][Full Text] [Related]
6. Effects of prostaglandin E1 infusion in the pre-operative management of critical congenital heart disease.
Ohara T; Ogata H; Fujiyama J; Murata Y; Abe J; Kakuta K; Hayamizu S; Kameyama S; Yoshida Y
Tohoku J Exp Med; 1985 Jun; 146(2):237-49. PubMed ID: 4040664
[TBL] [Abstract][Full Text] [Related]
7. Pharmacologic dilatation of the ductus arteriosus with prostaglandin E1 in infants with congenital heart disease.
Graham TP; Atwood GF; Boucek RJ
South Med J; 1978 Oct; 71(10):1238-41, 1246. PubMed ID: 81528
[TBL] [Abstract][Full Text] [Related]
8. Long-term prostaglandin E1 therapy in congenital heart defects.
Teixeira OH; Carpenter B; MacMurray SB; Vlad P
J Am Coll Cardiol; 1984 Mar; 3(3):838-43. PubMed ID: 6537955
[TBL] [Abstract][Full Text] [Related]
9. Pseudo-Bartter syndrome in a neonate on prostaglandin infusion.
Vanhaesebrouck S; Allegaert K; Vanhole C; Devlieger H; Gewillig M; Proesmans W
Eur J Pediatr; 2003 Sep; 162(9):569-71. PubMed ID: 12811550
[TBL] [Abstract][Full Text] [Related]
10. Administration of prostaglandin E1 in neonates with critical congenital cardiac defects.
Lewis AB; Takahashi M; Lurie PR
J Pediatr; 1978 Sep; 93(3):481-5. PubMed ID: 690772
[TBL] [Abstract][Full Text] [Related]
11. Prostaglandin E1 for maintaining ductal patency in neonates with ductal-dependent cardiac lesions.
Akkinapally S; Hundalani SG; Kulkarni M; Fernandes CJ; Cabrera AG; Shivanna B; Pammi M
Cochrane Database Syst Rev; 2018 Feb; 2(2):CD011417. PubMed ID: 29486048
[TBL] [Abstract][Full Text] [Related]
12. Prostaglandin E1 treatment of congenital heart disease: use prior to neonatal transport.
Buck ML
DICP; 1991 Apr; 25(4):408-9. PubMed ID: 1926911
[TBL] [Abstract][Full Text] [Related]
13. [Infusion of prostaglandin E1 in ductus-dependent congenital heart diseases. Analysis of 47 cases].
Atik E; Gutiérrez JA; Lyra Filho FJ; Iwahashi ER; Ribeiro IG; De Albuquerque AM; Barbero-Marcial M; Ebaid M
Arq Bras Cardiol; 1989 Aug; 53(2):93-7. PubMed ID: 2624556
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of low dose prostaglandin E1 treatment for ductus dependent congenital heart disease.
Kramer HH; Sommer M; Rammos S; Krogmann O
Eur J Pediatr; 1995 Sep; 154(9):700-7. PubMed ID: 8582419
[TBL] [Abstract][Full Text] [Related]
15. Alprostadil (Prostin VR Pediatric Sterile Solution, The Upjohn Company).
Roehl SL; Townsend RJ
Drug Intell Clin Pharm; 1982 Nov; 16(11):823-32. PubMed ID: 6756848
[TBL] [Abstract][Full Text] [Related]
16. Cortical hyperostosis simulating osteomyelitis after short-term prostaglandin E1 infusion.
Kalloghlian AK; Frayha HH; deMoor MM
Eur J Pediatr; 1996 Mar; 155(3):173-4. PubMed ID: 8929722
[TBL] [Abstract][Full Text] [Related]
17. Use of prostaglandins in duct-dependent congenital heart conditions.
Singh Y; Mikrou P
Arch Dis Child Educ Pract Ed; 2018 Jun; 103(3):137-140. PubMed ID: 29162633
[TBL] [Abstract][Full Text] [Related]
18. Oral prostaglandin E1 derivative (OP-1206) in an infant with double outlet right ventricle and pulmonary stenosis. Effect on ductus-dependent pulmonary circulation.
Saji T; Matsuura H; Hoshino K; Yamamoto S; Ishikita T; Matsuo N
Jpn Heart J; 1991 Sep; 32(5):735-40. PubMed ID: 1774835
[TBL] [Abstract][Full Text] [Related]
19. Reappraisal of the prostaglandin E1 dose for early newborns with patent ductus arteriosus-dependent pulmonary circulation.
Huang FK; Lin CC; Huang TC; Weng KP; Liu PY; Chen YY; Wang HP; Ger LP; Hsieh KS
Pediatr Neonatol; 2013 Apr; 54(2):102-6. PubMed ID: 23590954
[TBL] [Abstract][Full Text] [Related]
20. [Effect of preoperative administration of prostaglandin E1 on cerebral blood flow in newborns with ductal-dependent congenital cardiac malformations].
Simon M; Cucerea M; Dimitriu AG; Stamatin M
Rev Med Chir Soc Med Nat Iasi; 2010; 114(2):399-407. PubMed ID: 20700975
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
